MedWatch

GN Hearing CEO: OTC will increase price transparency on the hearing market

Consumers in the US will soon be able to buy a hearing aid over the counter. According to GN Hearing CEO, Gitte Aabo, the market change will hopefully allow people to better understand what they’re paying for, also when it comes to traditional hearing aids that include an audiologist visit.

Gitte Aabo, CEO of GN Hearing | Photo: GN Store Nord / PR

According to Gitte Aabo, CEO of GN Hearing, the upcoming sales channel for over-the-counter (OTC) hearing aids will give users more options to make the right choice when looking for a hearing loss solutions.

The existence of OTC hearing aid sales will create more transparency when it comes to what a user actually pays for the devices themselves, and what is added on top in the shape of the extra service offered by audiologists.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs